PISCATAWAY, N.J., Dec. 1 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that it has signed a non-exclusive Supply and Distribution Agreement with Utah Medical Products, Inc. (Nasdaq: UTMD), granting them rights to market and sell Milestone's proprietary CompuMed® computer-controlled injection system to its North American customer base.

Kevin Cornwell, Chief Executive Officer of UTMD, stated, "We believe the CompuMed system fits well with UTMD's focus to provide specialized, clinically effective solutions for women's health care, especially for the surgical management of [uterine] cervical disease."

With particular interest in health care for women and their babies, Utah Medical Products (www.utahmed.com) develops, manufactures, assembles and markets a broad range of well-established disposable and reusable specialty medical devices designed for better health outcomes for patients and their care providers.

Leonard Osser, Chief Executive Officer of Milestone, noted, "A key component to our long term growth strategy is building a strong, capable distribution network to actively market and sell Milestone's innovative computer-controlled injection technologies to both medical and dental practitioners worldwide. We are very pleased to be teaming with Utah Medical Products and look forward to working with them to heighten awareness in the medical community of CompuMed's many noted benefits- not the least of which is providing for painless injections."

CompuMed is a patented computer-controlled injection system geared to the needs of the medical market and allows many medical procedures, now requiring IV sedation, to be performed with only local anesthesia due to dramatic pain reduction. Also, dosages of local anesthetic can often be significantly reduced, thus reducing side effects, accelerating recovery times, lowering costs and eliminating potential complications. CompuMed has gained clinical evidence demonstrating benefits from use in colorectal surgery; podiatry; dermatology, including surgery for the removal of basal cell carcinomas and other oncological dermatologic procedures; nasal and sinus surgery, including rhinoplasty; hair transplantation and plastic surgery, among others.

About Milestone Scientific Inc.

Headquartered in Piscataway, New Jersey, Milestone Scientific is engaged in pioneering advanced computer-controlled injection technologies for the medical and dental markets; and currently sells its award-winning products through a global distribution network serving North America, Asia, Africa and Europe. For more information on the STA System and other innovative Milestone products, please visit the Company's web sites found at www.milestonescientific.com and www.STAis4U.com.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2008. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

        FOR MORE INFORMATION, PLEASE CONTACT:
         Elite Financial Communications Group
 Dodi Handy, President and CEO (Twitter: @dodihandy)
 For Media Inquiries: Kathy Addison, Director, Elite
         Media Group (Twitter: @kathyaddison)
      407-585-1080 or via email at mlss@efcg.net

SOURCE Milestone Scientific Inc.

Back to top

RELATED LINKS
http://www.milesci.com
http://www.utahmed.com